A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.
Am J Gastroenterol
; 111(11): 1599-1607, 2016 Nov.
Article
in En
| MEDLINE
| ID: mdl-27481309
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Crohn Disease
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Gastroenterol
Year:
2016
Type:
Article
Affiliation country:
United States